AIDS · 2005 · 154 citations · 36 references
Life SciencesImmunologyInfectious DiseasesApoptosisClinical ImmunologyImmunology Of Infectious DiseasesApoptosis In Immune CellsB Cell ActivationB Cell BiologyB-cell ResponsesHumoral ImmunityLymphocyte ActivationB Cell ApoptosisB Cell DysfunctionB Cell Responses To InfectionB-cell ImmunophenotypesB-cell Mediated ImmunityIntracellular ExpressionPrimary InfectionSurface Receptor Expression Analysis
OBJECTIVES: To investigate the effects of primary HIV-1 infection (PHI) and of two antiretroviral therapies [highly active antiretroviral therapy (HAART) or reverse transcriptase inhibitors (RTI)] on activation, differentiation and survival of B cells. METHODS: Naive and memory B cells from three groups [PHI (31), chronic infection (26) and healthy donors (12)] were studied for surface expression of Fas, LAIR-1, CD70, intracellular expression of Bcl-2 and spontaneous apoptosis. Fluorescence activated cell sorting (IgD+IgM+CD19+CD27+) and short-term cell culture to analyse induction of CD25 on B cells were performed in five patients with PHI. Patients with PHI were sampled at baseline, and after 1 and 6 months of therapy. Results were analysed by parametric and non-parametric tests and by mathematical modelling. RESULTS: In PHI, B cells were significantly decreased; naive and memory B lymphocytes showed a high degree of activation, manifested by hypergammaglobulinaemia, altered expression of Fas and LAIR-1, and high rate of spontaneous apoptosis. Antiretroviral treatment improved the activation/differentiation status of B cells, reduced apoptosis to levels comparable to those in healthy individuals and restored the ability of B cells to respond to T cell-dependent activation. B cells showed slightly better recovery in patients taking HAART than in those taking RTI. Decreased IgM-positive memory B cells and lower induction of CD25 expression on B cells upon T cell activation at diagnosis of PHI was shown in five patients tested. These parameters normalized after 6 months of therapy. CONCLUSION: B cell dysfunctions found in chronic HIV-1 infection appear during PHI and initiation of antiretroviral therapy early during infection may help to preserve the B cell compartment.
36
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Frédéric Rieux‐Laucat, Françoise Le Deist, Claire Hivroz et al. · Science · 1995 · 1.3K citations
Life Sciences, Immunology, Pathology +17
HIV preferentially infects HIV-specific CD4+ T cells
Daniel C. Douek, Jason M. Brenchley, Michael R. Betts et al. · Nature · 2002 · 1.3K citations
Immune control of HIV-1 after early treatment of acute infection
Eric Rosenberg, Marcus Altfeld, Samuel Poon et al. · Nature · 2000 · 998 citations